Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Michael J. Rovito PhD, CHES, FMHI

Articles by Michael J. Rovito PhD, CHES, FMHI

Testis Ca screening: Why USPSTF ‘D’ grade is misguided

ByMichael J. Rovito PhD, CHES, FMHI,Ajay K. Nangia, MBBS

February 14th 2019

No evidence currently exists to suggest screening is either harmful or beneficial.

Latest Updated Articles

Testis Ca screening: Why USPSTF ‘D’ grade is misguided
Published: February 14th 2019 | Updated:

Trending on Urology Times

Permanent J code for mitomycin for intravesical solution now in effect

Beyond the clinic: Physician presence on social media

FDA updates in urology: December 2025

GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance

Real-World Evidence in mCSPC Management